GLRX and Parkinson disease: Particularly, some pathologic conditions, such as inflammatory bowel disease [43,44] and Parkinson’s disease [45], have been associated with glutathione oxidation and application of the Grx1-roGFP2 derivatives to in vitro pathologic models may bring new information regarding the redox modulation during pathogenesis.